Cardium Goes to Market with Naturex’s CereBoost Cognitive Ingredient
A clinical study published in Psychopharmacology last year showed that a 200-mg CereBoost dose, the same dose used in Cerex, increased attention and working memory for up to six hours.
As part of its MedPodium brand, Cardium Therapeutics has now commercially launched Cerex, a product based on cognitive-health ginseng ingredient CereBoost from Naturex (Avignon, France). The product is designed to support focus, memory, and attention.
CereBoost is a standardized, North American source of ginsenoside, standardized to 10 to 12% ginsenoside concentration, from American ginseng (Panax quinquefolius). According to the companies, a randomized, double-blind, placebo-controlled crossover study in 32 healthy young adults published in Psychopharmacology last year showed that a 200-mg CereBoost dose, the same dose used in Cerex, increased attention and working memory for up to six hours. The clinical study was purportedly the first to characterize the use of American ginseng for cognitive health.
“We plant to initially market Cerex to college students, working professionals, and seniors who seek a safe and easy-to-use dietary supplement intended to support cognitive function,” said Cardium chairman and CEO Christopher Reinhard. “In view of widespread press reports about the extensive off-label use of stimulant-based, addictive-prone ADD/ADHD drugs on college campuses throughout the U.S., we believe that MedPodium’s Cerex could offer a safe and natural alternative.”
New review paper highlights gut-brain benefits of novel herbal blend, Digexin
September 16th 2024NXT USA has announced the publication of a narrative review that offers an in-depth analysis of the efficacy and safety of its Digexin ingredient, which is a novel blend of Ashwagandha and okra extracts.
